PURE Bioscience announces Liolios Group for new investor relations programme
Mar 12, 2013 (M2 EQUITYBITES via COMTEX) --
Antimicrobial company PURE Bioscience (NASDAQ:PURE) reported on Monday that it has selected Liolios Group to lead its new investor relations and financial communications campaign.
"Our SDC molecule quickly and completely eliminates the triple threat of viruses, bacteria and fungus, yet is 'generally recognized as safe' as a contact biocide," said Michael L. Krall, president and CEO of PURE Bioscience. "Our focused technical sales strategy is creating increasing market recognition and acceptance of our patented PURE products across a broad range of industries and applications."
The Liolios Group and PURE Bioscience partnership will strengthen the latter's investor communications activity and expand its interaction with the investment community.
Comments on this story may be sent to email@example.com
[ Back To Technology News's Homepage ]